Purchase Order 75F40119P10302
Award Date 7/17/19
Potential Completion Date 6/30/23
Potential Value $228K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed-price purchase order valued at $211,279.00 to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of the AMBR250 4-WAY MODULAR SYSTEM, which is a bioreactor product used to support the biopharmaceutical manufacturing process. Sartorius Stedim North America Inc. is a leading provider of laboratory equipment, consumables,...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The $198,816.00 fixed-price contract is for maintenance on a Sartorius Biostat B-DCU II parallel bioreactor system. The contract has no set-aside designation and was awarded on December 20, 2018, with a completion date of January 1, 2022. Sartorius Stedim North America Inc. has...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The $89,489.60 Firm Fixed Price Purchase Order is for the supply of bioreactor parts and accessories. The contract does not have a set-aside designation. Sartorius Stedim North America Inc. is a leading provider of laboratory...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, to provide an AMBR15 analysis module equipped with BioPAT Spectro hardware and flow cell. The contract has a potential value of $90,507.50 and a completion date of November 17, 2023. No set-aside designation was used for this award. Sartorius Stedim North America Inc. is a...
- Sartorius Stedim North America, Inc. was awarded a $126,870 purchase order by the Department of Health and Human Services' Food and Drug Administration to provide bioreactor parts and components. As the prime contractor, Sartorius Stedim North America will deliver the requested biomanufacturing equipment components from its Bohemia, New York facility in support of the FDA's regulatory and research programs. The firm fixed price contract runs from August 2023 through September 2024. No set...
- This is a $21,343.18 firm fixed-price purchase order contract awarded by the Plains Area agency to Sartorius Stedim North America Inc., a foreign-owned for-profit subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the provision of a SARTORIUS BIOSTAT A BIOREACTOR. No set-aside was used for this award. Sartorius Stedim North America Inc. is a leading supplier of advanced laboratory equipment, consumables, and services to various federal agencies, including the...
- The Food and Drug Administration awarded a $86.8K firm fixed-price purchase order to Sartorius Stedim North America Inc. for operational parts and software updates to Biostat B-DCU II bioprocess control units equipped with BioPat analytics systems. The contract, awarded on September 17, 2019, with a completion date of January 30, 2020, represents a non-set-aside procurement for specialized biopharmaceutical manufacturing support equipment. Sartorius Stedim North America Inc., a subsidiary of...
- This is a firm-fixed-price purchase order awarded by the Plains Area division of an unspecified federal agency to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The $215,273.00 contract is for the installation and training of large-scale bioreactors, which are essential for efficiently producing biologics in quantities suitable for commercial scale-up operations while maintaining quality. The contract has an ultimate completion date of...
- This is a $17,904.60 firm fixed-price purchase order awarded by a civilian federal agency to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The award is for a BIOSTAT A UNIVESSEL (BIOREACTOR 1L) reference quotation #1411-MHH-5980. This contract was not set aside and does not appear to be associated with a larger contract vehicle. Sartorius Stedim North America Inc. is a leading provider of advanced laboratory equipment, consumables, and...
- This is a $6,806 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of 01-GMP TPO, 50UG, a biopharmaceutical product or laboratory equipment, with a period of performance through April 17, 2025. Sartorius Stedim North America is a leading provider of laboratory equipment, consumables, and services supporting...
The Department of Health and Human Services Food and Drug Administration awarded a $227,968.50 firm fixed price purchase order for service and maintenance on a Sartorius Stedim North America Inc. Ambr 15 bioreactor system. The contract has a completion date of June 30, 2023 and was awarded on a competitive basis with no set-aside designation. Sartorius Stedim North America Inc. is the prime contractor, a division of the German company Sartorius Aktiengesellschaft, and has fulfilled over $2 million in federal contracts since 2019 to provide laboratory equipment and consumables supporting biopharmaceutical research and manufacturing for government agencies.
Generated 3/23/24, 8:51 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Preventative Maintenance on TAP Biosystems Ambr 15 | FDA-SOL-1213591 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/1 | 5/7/19, 2:41 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $55.9k | 1/12/22 | |
| P00002 | Exercise an Option | $55.9k | 4/29/21 | |
| P00001 | Exercise an Option | $55.9k | 1/14/20 | |
| Not listed | Not listed | $60.2k | 7/17/19 |